Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its overexpression has been widely demonstrated to occur in various types of cancer. Overexpression of survivin also correlates with tumor progression and induces anticancer drug resistance. Interestingly, recent studies reveal that survivin exhibits multiple pro-mitotic and anti-apoptotic functions; the differential functions of survivin seem to be caused by differential subcellular localization, phosphorylation, and acetylation of this molecule. In this review, the complex expression regulations and post-translational modifications of survivin are discussed. This review also discusses how recent discoveries improve our understanding of survivin biology and also create opportunities for developing differential-functioned survivin-targeted therapy. Databases such as PubMed, Scopus® (Elsevier, New York, NY, USA), and SciFinder® (CAS, Columbus, OH, USA) were used to search for literature in the preparation of this review.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804542 | PMC |
| http://dx.doi.org/10.2147/OTT.S33374 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Temporal RAGE Over-Expression Disrupts Lung Development by Modulating Apoptotic Signaling.
Curr Issues Mol Biol
December 2024
Department of Cell Biology and Physiology, Brigham Young University, 3054 Life Sciences Building, Provo, UT 84602, USA.
Receptors for advanced glycation end products (RAGE) are multiligand cell surface receptors found most abundantly in lung tissue. This study sought to evaluate the role of RAGE in lung development by using a transgenic (TG) mouse model that spatially and temporally controlled RAGE overexpression. Histological imaging revealed that RAGE upregulation from embryonic day (E) 15.
View Article and Find Full Text PDFSurvivin modulates stiffness-induced vascular smooth muscle cell motility.
bioRxiv
December 2024
Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, NY 14203, USA.
Arterial stiffness is a key contributor to cardiovascular diseases, including atherosclerosis, restenosis, and coronary artery disease, it has been characterized to be associated with the aberrant migration of vascular smooth muscle cells (VSMCs). However, the underlying molecular mechanisms driving VSMC migration in stiff environments remain incompletely understood. We recently demonstrated that survivin, a member of the inhibitor of apoptosis protein family, is highly expressed in both mouse and human VSMCs cultured on stiff polyacrylamide hydrogels, where it modulates stiffness-mediated cell cycle progression and proliferation.
View Article and Find Full Text PDFProtective effect of Auraptene, a novel acetylcholinesterase inhibitor, on hydrogen peroxide-induced cell toxicity in PC12 cells.
Toxicol Res (Camb)
December 2024
Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Khorasan Razavi, Mashhad, Azadi Square, 9177948954, Iran.
Objective: Alzheimer's disease (ad) is a progressive and degenerative disorder of the central nervous system that is associated with cognitive and memory impairment. The main factors which have been implicated in neurodegeneration of ad are oxidative stress and cholinergic neurons dysfunction. Here, we examined the effects of auraptene, a novel acetylcholinesterase (AChE) inhibitor, on hydrogen peroxide (HO)-induced cell death in PC12 cells.
View Article and Find Full Text PDFBIRC5 as a prognostic and diagnostic biomarker in pan-cancer: an integrated analysis of expression, immune subtypes, and functional networks.
Front Genet
December 2024
School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Article Synopsis
- BIRC5 (Survivin) is an anti-apoptotic protein found to be overexpressed in 33 different types of cancer, leading to increased tumor growth and resistance to treatment.
- The study utilized RNA-seq and protein expression data to assess BIRC5 levels in tumor versus normal tissues, revealing strong correlations between its expression and various cancer subtypes, along with a significant association with poor patient prognosis.
- The research highlights BIRC5's potential as a diagnostic and prognostic biomarker, as well as a therapeutic target due to its impact on cell proliferation and interaction with the immune microenvironment.
RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer.
Cell Commun Signal
December 2024
Department of Molecular Biosciences, The University of Kansas, Lawrence, KS, 66045-7534, USA.
Article Synopsis
- The RNA-binding protein HuR is crucial in cancer progression, often preventing cell death, and its inhibition can lead to cancer cell death, which is not fully understood.
- The study explored the effects of the small molecule inhibitor KH-3 on various cancer cell lines, particularly breast and prostate cancers, finding that it induced cell death through apoptotic mechanisms, autophagy, and ferroptosis.
- KH-3's effectiveness was confirmed in mouse models and was linked to reduced levels of HuR target proteins involved in cell survival, suggesting that inhibiting HuR may serve as a potential cancer treatment strategy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!